Health
China approves first oral GLP-1 weight-loss pill
Medical Xpress·November 13, 2026

China has approved its first orally administered GLP-1 weight-loss drug, permitting Eli Lilly to sell its orforglipron pill in a market where 630 million adults could be overweight or obese by 2050.
Read the full story at Medical Xpress →